Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/4/2025

Management of Gestational Diabetes Mellitus in Late Pregnancy

Diagnosis and Admission Criteria

  • The American Diabetes Association recommends admission for immediate evaluation and initiation of insulin therapy in patients with an OGTT value of 230 mg/dL, which represents severe hyperglycemia that far exceeds diagnostic thresholds for gestational diabetes 1, 2
  • An OGTT value of 230 mg/dL dramatically exceeds all diagnostic thresholds, with diagnostic cutoffs being 92 mg/dL fasting, 180 mg/dL at 1-hour, or 153 mg/dL at 2-hour 1
  • Severe glycosuria (4+) indicates significant hyperglycemia with renal glucose threshold exceeded 3
  • Late gestational age (34 weeks) requires immediate intervention to prevent fetal macrosomia and other complications 2, 4

Initial Hospital Management Protocol

  • The American College of Obstetricians and Gynecologists recommends obtaining fasting plasma glucose and HbA1c to differentiate GDM from preexisting diabetes (HbA1c ≥6.5% or fasting glucose ≥126 mg/dL suggests preexisting diabetes) 5
  • Check baseline electrolytes including potassium before starting insulin therapy, as recommended by the American Diabetes Association 6
  • Perform comprehensive metabolic panel including renal function, as recommended by the American College of Obstetricians and Gynecologists 2
  • Check for ketonuria, as women with diabetes in pregnancy are at high risk for ketosis even with moderate hyperglycemia 6
  • Obstetric ultrasound to assess fetal size, amniotic fluid volume, and estimated fetal weight for macrosomia, as recommended by the American Institute of Ultrasound in Medicine 2

Glycemic Targets During Pregnancy

  • The American Diabetes Association recommends establishing strict glucose monitoring with the following targets: fasting glucose <95 mg/dL, 1-hour postprandial <140 mg/dL, and 2-hour postprandial <120 mg/dL 2, 4, 7

Insulin Initiation

  • The American College of Obstetricians and Gynecologists recommends insulin as the mandatory first-line treatment for patients with severe hyperglycemia, given the severity of hyperglycemia 2, 4, 7
  • Start insulin immediately, without attempting lifestyle modification alone, as recommended by the American Diabetes Association 2
  • Typical starting dose is 0.7-1.0 units/kg of pre-pregnancy or current body weight divided as basal-bolus regimen, as recommended by the Endocrine Society 2
  • Insulin does not cross the placenta to a measurable extent, making it the safest option, as stated by the American College of Obstetricians and Gynecologists 2, 7

Monitoring Protocol During Hospitalization

  • The American Diabetes Association recommends self-monitoring of blood glucose 4-7 times daily, with fasting and 1-hour or 2-hour postprandial measurements after each meal 5, 2
  • Monitor potassium levels every 4-6 hours while on insulin therapy due to intracellular potassium shift, as recommended by the American Heart Association 6
  • Daily fetal kick counts and consider non-stress testing given severity of hyperglycemia, as recommended by the American College of Obstetricians and Gynecologists 8
  • Blood pressure monitoring for hypertensive disorders, which are increased in risk with GDM, as recommended by the American Heart Association 8

Medical Nutrition Therapy

  • The Academy of Nutrition and Dietetics recommends consultation with a registered dietitian familiar with GDM management, with a minimum of 175g carbohydrate, 71g protein, and 28g fiber daily 2, 7
  • Distribute carbohydrates across three meals and 2-3 snacks to minimize postprandial excursions, as recommended by the American Diabetes Association 2
  • Avoid caloric restriction, as adequate calories are needed for fetal growth at 34 weeks, as stated by the American College of Obstetricians and Gynecologists 2

Fetal Surveillance Plan

  • The American College of Obstetricians and Gynecologists recommends initiating fetal surveillance at 32 weeks with twice-weekly non-stress tests, and weekly ultrasound to monitor fetal growth and amniotic fluid volume 8
  • Assess for fetal macrosomia, which increases the risk of shoulder dystocia, as recommended by the American Institute of Ultrasound in Medicine 8

Delivery Planning

  • The American College of Obstetricians and Gynecologists recommends planning delivery timing based on glycemic control achieved, with delivery at 39 0/7 to 39 6/7 weeks gestation if requiring insulin/medications, and at 39 0/7 to 40 6/7 weeks if glucose controlled with lifestyle alone 8
  • Consider cesarean delivery if estimated fetal weight >4500g due to shoulder dystocia risk, as recommended by the American College of Obstetricians and Gynecologists 8
  • Do not deliver before 38 weeks unless obstetric indications exist, as stated by the American College of Obstetricians and Gynecologists 8

Critical Pitfalls to Avoid

  • The American Diabetes Association recommends not delaying insulin initiation, as this glucose level will not respond to lifestyle modification alone 2, 4
  • Do not use oral agents as first-line therapy, due to inadequate efficacy and placental transfer concerns, as stated by the American College of Obstetricians and Gynecologists 4, 7
  • Urine glucose monitoring is not useful for management decisions, as recommended by the American Diabetes Association 8
  • Do not use HbA1c alone for monitoring during pregnancy, instead use self-monitored blood glucose, as recommended by the American College of Obstetricians and Gynecologists 5
  • Monitor for hypoglycemia once insulin started, particularly overnight, as recommended by the American Diabetes Association 4

Postpartum Management

  • The American College of Obstetricians and Gynecologists recommends that insulin requirements drop dramatically immediately postpartum, roughly 34% lower than pre-pregnancy 9
  • Perform 75g OGTT at 4-12 weeks postpartum using non-pregnant criteria to assess for persistent diabetes, as recommended by the American Diabetes Association 5, 9
  • Lifelong screening every 2-3 years, as this patient has a 10-fold increased risk of type 2 diabetes, as stated by the American Diabetes Association 9
  • Encourage breastfeeding, which may reduce long-term diabetes risk, as recommended by the American Academy of Pediatrics 9